RavenQuest Announces Significant Supply Agreement With Wayland Group

RavenQuest BioMed Inc. (CSE: RQB  OTCQB: RVVQF  Frankfurt: 1IT) and Wayland Group (CSE:WAYL) (OTCQB:MRRCF) are pleased to announce that they have entered into a supply agreement whereby Wayland will buy up to 8,000 kg of dried flower cannabis from RavenQuest in 2019.  The quantity will be sent during 2019 as product becomes available.

Wayland will make a payment of $2 million to RavenQuest.  Pricing for the trade is similar with prevailing cannabis prices.

“as we both do our part to fulfill the demand for cannabis across Canada, & rdquo George Robinson, CEO of RavenQuest RavenQuest is excited to be working with Wayland.  “Negotiations were smooth and with no significant challenges; his team at Wayland and Ben Ward are a pleasure to work with. This distribution agreement is a significant win for either side of the trade. For RavenQuest’s rdquo, & part, 8,000 kg represents about 80% of our production for 2019, meaning this transaction provides us more certainty when it comes to selling our 2019 generation at competitive prices ; Robinson continued.

“We’re thrilled to be working with George and his team at RavenQuest to provide their specialty merchandise through our current distribution network to recreational cannabis customers across Canada. This arrangement provides for efficiencies for both companies, constructively working together to meet with demand . At the exact same time, this allows us to channel stated Ben Ward, CEO of Wayland, & rdquo; our current supply to the market.

Maricann Group Inc., through its subsidiaries, is working under the Wayland Group name. For further details see the press release dated September 24, 2018.

Around RavenQuest BioMed Inc..

RavenQuest BioMed Inc. is a diversified publicly traded cannabis company with branches focused upon cannabis production, management services & consulting and specialized research & development. RavenQuest is a certified manufacturer with facilities located in Markham, Ontario and Edmonton, Alberta. RavenQuest maintains a research partnership with Montreal’s McGill University focused upon cultivar (strain) recognition, plant stabilization and yield maximization of the cannabis plant. The business focuses on partnerships with Indigenous communities.

Around Wayland Group

Wayland is a cultivator and chip of cannabis. The business was founded in 2013 and is based in Burlington, Ontario, Canada and Munich, Germany, with production facilities in Langton, Ontario where it operates a cannabis cultivation, extraction, formulation, and distribution business under federal licenses in the Government of Canada. The Business has production operations in Argentina and now Dresden, Saxony, Germany Switzerland Piedmont Ibague, Colombia UK. Wayland will continue to pursue new opportunities worldwide in its attempt to improve lives through cannabis.

On Behalf of the Board of Directors of 
RAVENQUEST BIOMED INC..

“George Robinson”

For further information, please contact:

Neither the Canadian Securities Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this press release, which has been prepared by management.

Cautionary Note Regarding Forward-Looking Statements

All statements in this press release, other than statements of historical fact, are “forward-looking info ” with regard to the Company within the meaning of applicable securities laws, including statements with regard to the fulfillment of cannabis orders and payment therefore pursuant to the supply arrangement with Maricann, the first shipment of cannabis flower in March 2019 and its estimated 2019 cannabis production. Statements are provided by the business for the purpose of conveying information about current expectations and plans regarding the future and readers are cautioned that such statements might not be appropriate for different purposes. By its nature, this information is subject to inherent risks and uncertainties that may be general or specific and which give rise to the possibility that predictions, expectations, predictions, projections or decisions will not prove to be true, that assumptions might not be correct and that objectives, strategic objectives and priorities will not be achieved. These risks and uncertainties include but aren’t limited to those identified and reported in the organization ’s public filings under the business ’s SEDAR profile in www.sedar.com.  Even though the Company has attempted to identify important factors that could cause actual actions, events or results to differ materially from those described in forward-looking information, there might be other factors that cause actions, events or results not to be as anticipated, estimated or intended. There can be no assurance that such information will prove to be accurate as actual results and future events could differ materially from those anticipated in such statements.  The Company disclaims any intention or obligation to update or revise any forward-looking information, whether as a result of new information, future events or otherwise unless required by law.

Released at Tue, 18 Dec 2018 18:21:03 +0000

Posted in: News

Comments are closed.